ArticleJournal of medical case reports2022

Efficacy of lorlatinib after alectinib-induced interstitial lung disease in a patient with anaplastic lymphoma kinase-positive non-small cell lung cancer: a case report.

Fumihiro Kashizaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.